you know i think there's so much prejudice still there and it's kind of more covert now people used to be more clear and say you know well i believe in this or i believe in that and now
People used to be more upfront about their prejudices.
The FDA's assessment of the costs and benefits of regulatory alternatives have led to the proposition of an approach that neglects to maximize net benefits.